Problems and solutions in the development of plastic bottles for medical use

First, the existing problems

In recent 10 years, the development of medical plastic containers is fast.

However, after a calm analysis, it can be seen that this development is a result of the combination of GMP reform and the introduction of high-quality medical plastic containers into China.

On the one hand, it proves the necessity of developing medical plastic containers, on the other hand, it also exposes the problems existing in the development of medical plastic containers in China.

1. Low level of intensification and lack of strategic layout

A considerable number of pharmaceutical plastic container manufacturers started to use plastic containers after many of them switched from the original glass container washing process.

This resulted in a large number of pharmaceutical plastic container factories in a short period of time, and then a number of enterprises quickly closed.

In the further development of plastic pharmaceutical containers, the enterprise is basically in a spontaneous state, no macro guidance.

2. It is only promoted by individual enterprises

Pharmaceutical plastic containers are involved in chemical materials, mechanical manufacturing, digital control and other aspects, and they are highly integrative. It is difficult for pharmaceutical plastic containers manufacturers to catch up with the world level.

Although in recent years, the scale and number of plastic containers for medicinal use in China have developed rapidly, they basically follow behind others, with few patents and original inventions.

To change this situation, a tissue suitable for the development of medicinal plastic containers and adequate inputs are needed.

3. Low management level

On the one hand, in order to take care of the actual level of many pharmaceutical plastic container manufacturers, the quality standards are not in line with the international level.

Medicinal plastic container, on the other hand, detection means is relatively backward, and some companies drug itself is not the problem, but within the plastic bottles on the density is not high, because of its resistance to wet permeability and resistance is not strong, lead to oxidizing discoloration contents, deterioration, investigate its reason is lack of medicinal plastic containers density uniformity testing instrument.

Second, the solution

1. To establish the concept that the medicinal packaging container is part of the medicine

Although it is well known that medicines must come in a package, many people do not really see such products as part of the medicine.

For example, discussions of the development of the pharmaceutical industry tend to focus on specific drugs and rarely on the development of medicinal containers.

When researching policy, little thought has been given to encouraging innovation in medicinal containers.

This is actually one-sided.

The Chinese Pharmacopoeia states that medicines contain contents, packaging and labelling instructions.

The definition of pharmaceutical packaging as an organic component of medicines gives us a clear direction for the development of pharmaceutical plastic containers.

2. Implement high quality and high price for medicinal containers

Some well-known foreign pharmaceutical enterprises attach great importance to the selection of pharmaceutical containers. They not only care about the appearance, but also pay close attention to the internal quality and more care about the equipment of producing plastic containers.

That cost is reflected in the price of its medicines.

And our drug pricing basically does not consider the pharmaceutical container factor, pharmaceutical enterprises in order to seek low cost, it is difficult to consciously pursue high-quality packaging container.

3. Support and support the research and development of new pharmaceutical plastic containers

In the process of industrial development layout and new drug research and development planning and investment, pharmaceutical plastic containers should have their due status.

Corresponding encouragement policies should be formulated to support pharmaceutical enterprises and pharmaceutical plastic packaging manufacturing enterprises in their research and innovation on pharmaceutical plastic containers, so as to shorten the gap between China's pharmaceutical plastic containers and the international advanced level as soon as possible and create necessary conditions for China's pharmaceutical industry to enter the world.

4. Strengthen the management of pharmaceutical plastic containers

Aim at the world's advanced level and gradually improve the quality standard of medical plastic containers on the current basis;

It is necessary to strengthen the construction of testing sites and means for medical plastic containers, so that all kinds of medical plastic containers can be fully included in the drug testing system and get timely and accurate testing.

At the same time, the market management of medical plastic containers should be further strengthened to prevent the occurrence of malicious competition such as cutting corners, adulteration and shoddy goods, so as to ensure the health of the medical plastic containers industry.

Sustained and rapid development.